Literature DB >> 27287255

Aberrant hippocampal Atp8a1 levels are associated with altered synaptic strength, electrical activity, and autistic-like behavior.

Daniel J Kerr1, Alexandra Marsillo1, Sara R Guariglia2, Tatyana Budylin1, Rodina Sadek3, Silvia Menkes3, Abha Chauhan4, Guang Y Wen5, Daniel P McCloskey6, Andrzej Wieraszko7, Probal Banerjee8.   

Abstract

Type IV ATPases are putative aminophospholipid translocases (APLTs), more commonly known as flippases. A pronounced induction of the flippase Atp8a1 was observed in post-mortem tissue homogenates from the hippocampus and temporal lobe of juvenile autistic subjects compared to age-matched controls. In order to simulate the human data, C57BL/6 mice were allowed to develop after intra-hippocampal injection of recombinant lentivirus expressing Atp8a1 at the early developmental stage of postnatal day 6 (P6). Transmission electron microscopy (TEM) analysis of the lentivirus-Atp8a1 treated (Atp8a1+) mice in adulthood revealed fewer and weaker excitatory synapses in the hippocampal CA1 region compared to mice injected with empty virus. Significant inhibition of the Schaffer collateral pathway was observed in the Atp8a1+ mice in paired-pulse recording (PPR) at 20-ms inter-stimulus interval. In the three-chambered sociability test, the Atp8a1+ mice displayed no preference for an encaged stranger mouse over a novel object, which is a characteristic autistic-like behavior. In sharp contrast, Atp8a1 (-/-) mice displayed a preference for a stranger mouse over the novel object, which is characteristic of neurotypical mouse behavior. However, similar to the Atp8a1+ mice, the Atp8a1 (-/-) mice harbored fewer and weaker excitatory synapses in CA1 compared to wild-type controls, and displayed inhibition at 20-ms inter-stimulus interval in PPR. These findings suggest that both elevated and diminished levels of Atp8a1 during early development are detrimental to brain connectivity, but only elevated Atp8a1 is associated with aberrant social behavior. Mice with augmented levels of Atp8a1 may therefore serve as a potential model in autism research.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atp8a1; Autism; Flippase; Lenti-virus; Synaptic strength; TEM

Mesh:

Substances:

Year:  2016        PMID: 27287255     DOI: 10.1016/j.bbadis.2016.06.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  CIS-Acting Allele-Specific Expression Differences Induced by Alcohol and Impacted by Sex as Well as Parental Genotype of Origin.

Authors:  Chiao-Ling Lo; Lawrence Lumeng; Richard L Bell; Tiebing Liang; Amy C Lossie; Williams M Muir; Feng C Zhou
Journal:  Alcohol Clin Exp Res       Date:  2018-06-09       Impact factor: 3.455

2.  Phospholipid-flippase chaperone CDC50A is required for synapse maintenance by regulating phosphatidylserine exposure.

Authors:  Tao Li; Diankun Yu; Hayeon C Oak; Beika Zhu; Li Wang; Xueqiao Jiang; Robert S Molday; Arnold Kriegstein; Xianhua Piao
Journal:  EMBO J       Date:  2021-09-29       Impact factor: 11.598

3.  Sex differences in the effects of prenatal bisphenol A exposure on autism-related genes and their relationships with the hippocampus functions.

Authors:  Surangrat Thongkorn; Songphon Kanlayaprasit; Pawinee Panjabud; Thanit Saeliw; Thanawin Jantheang; Kasidit Kasitipradit; Suthathip Sarobol; Depicha Jindatip; Valerie W Hu; Tewin Tencomnao; Takako Kikkawa; Tatsuya Sato; Noriko Osumi; Tewarit Sarachana
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

Review 4.  Modelling Autism Spectrum Disorder (ASD) and Attention-Deficit/Hyperactivity Disorder (ADHD) Using Mice and Zebrafish.

Authors:  Godfried Dougnon; Hideaki Matsui
Journal:  Int J Mol Sci       Date:  2022-07-07       Impact factor: 6.208

Review 5.  The potential of induced pluripotent stem cells for discriminating neurodevelopmental disorders.

Authors:  Ricarda Stock; Pauline Jeckel; Udo Kraushaar; Richard Wüst; Andreas Fallgatter; Hansjürgen Volkmer
Journal:  Stem Cells Transl Med       Date:  2020-08-31       Impact factor: 6.940

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.